ARKAT, USA, Inc.
Aminocyclitols are of interest as glucosidase inhibitors, as probes for the study of pseudoglycosyltransferases, and as potential therapeutics for the treatment of Gaucher’s disease. The synthesis of these targets was reviewed in early 2008, and the aim of this review is to cover material relevant to the synthesis of aminocyclitols since that time. While not a focus of this review, biological evaluation of compounds will be presented where it is recorded in the literature.
Donaldson, William, "Recent progress in the synthesis of six-membered aminocyclitols (2008-2017)" (2018). Chemistry Faculty Research and Publications. 969.
ADA accessible version